Authors


Ryan Chandanais, MS, CPhT

Latest:

Bispecific Antibodies: The Next Generation of Immunotherapy

Advances in biotechnology have improved the production and recombination of antibodies, leading to improvements in monoclonal antibody therapies.



Gordon J. Vanscoy, PharmD, MBA

Latest:

Rare Pharmacy Emerges From Specialty, Part 2

Challenges and impact of rare diseases are faced by pharmacy stakeholders.


Kevin J Rivers, PharmD, MAD-ID

Latest:

Initiating an Antimicrobial Stewardship Program: The Costs and the Benefits

For decades, our growing and reliable arsenal of antibiotic and antimicrobial drugs created a dangerously cavalier attitude toward the nature of microbial pathogens and the true threat to public health they represent.


Brian W. Bresnahan, PhD

Latest:

Findings Related to Assessing Value for Private US Health Plans

A qualitative survey and quantitative database analysis of US payers indicated that determining whether they receive value for their expenditures involves substantial challenges.


Jennifer M. Hale, PharmD Candidate

Latest:

The Impending Patent Cliff: Implications for Pharmacists

As blockbuster drugs begin losing patent protection, pharmaceutical companies and pharmacists will address key marketplace changes.


Mike Hennessy, President, Chairman, Chief Executive Officer

Latest:

Specialty Pharmacy: Making a Difference

We welcome our new editorial advisory board member, a leader and innovator in the industry.


Steven J. Sheris, MD, FACC, FACP

Latest:

Examining New Treatment Strategies Aimed at Stroke Prevention in Patients with Atrial Fibrillation: A Multidisciplinary Discussion

Pharmacists can learn about educating patients on the risk of stroke in atrial fibrillation, monitoring anticoagulation therapy, and participating in disease management opportunities.


Ben Harding, PharmD candidate

Latest:

Pharmacist In Action: Pandemic Delivers Student a Unique Rotation

Ben Harding, a P4 student, discusses the scenario of being a pharmacy student during the COVID-19 pandemic.



Mohamed Jalloh, PharmD

Latest:

Hypertension: Revealing the Silent Killer

Hypertension is a leading modifiable risk factor for heart disease and stroke.



Karen von Koeckritz, PharmD

Latest:

Generic Drug Trends-What's Next?

Big changes are coming in the generic marketplace worldwide in the coming decade.


Rita El-Khoury, PharmD Candidate

Latest:

Case Studies (January 2020)

What could be causing this patient's involuntary, repetitive movements in her arms and legs?



Vincent Ducoulombier, MD

Latest:

Contribution of Phone Follow-up to Improved Adherence to Oral Osteoporosis Treatment

The authors studied the usefulness of a regular telephone follow-up to improve adherence to oral antiosteoporosis treatments. Their results support such follow-up and the use of this strategy in routine clinical practice.


Brahim K. Bookhart, MBA, MPH

Latest:

Economic Model Comparing Rivaroxaban and Enoxaparin for Post-Orthopedic VTE Prophylaxis

This analysis evaluates-from a US payer's perspective-the economic impact of using rivaroxaban versus enoxaparin for thromboprophylaxis following total hip or knee replacement surgery.


Chief Medical Officer, Cardinal Health Specialty Solutions

Latest:

Trends That Will Affect Specialty Health Care Into the Future 

Current developments and innovations that will shape the future of specialty pharmacy.


Kimberly Firtz, PharmD, MSPBA Candidate

Latest:

The Benefits of the Hub for Specialty Patients

Pharmaceutical manufacturers depend on hubs to act as connectors between various stakeholders across the specialty drug prescribing process.


Joseph S. Ross, MD, MHS

Latest:

Cancer Therapeutic Clinical Trials Supporting FDA Approval and Compendia Inclusion

Evidentiary standards for new or supplementary cancer therapeutic indication approvals by the FDA are consistent with off-label indication inclusions on Medicare-referenced compendia.


Jocelyn Zazyczny Konrad, RPh

Latest:

The Road to Wellness

A chain pharmacy implements an integrated care program featuring pharmacists and health care coaches who provide in-store counseling.


James P. Tursi, MD

Latest:

Costs of Collagenase Clostridium Histolyticum and Fasciectomy for Dupuytren's Contracture

A retrospective cohort analysis was conducted to compare disease-specific healthcare resource utilization and the costs of collagenase clostridium histolyticum and fasciectomy among adult Dupuytren’s contracture patients.


Sheila Seed, PharmD, MPh, CTH, AFTM, RCPS (GLASG)

Latest:

Point-of-Care Testing Offers New Opportunities

Consider these steps for pharmacists to further evolve their role as the pandemic continues to put pressure on the health care system.


Susan Goodin, PharmD, FCCP, BCOP

Latest:

Safe Handling of Oral Chemo Agents in Community Settings

Dr. Goodin is the director of the division of pharmaceutical sciences at the Cancer Institute of New Jersey and associate professor of medicine, division of medical oncology, University of Medicine and Dentistry of New Jersey/Robert Wood Johnson Medical School, New Brunswick.


Frederick L. Newman, PhD

Latest:

Quantitative Analysis of 2 Treatment Options for Osteoarthritis in Adults: Intra-Articular Hyaluronan Products and Diacerein

Empirical findings suggest that hyaluronan injections and diacerein are similarly effective. Yet the authors found that monetary savings could be realized when conservative treatment with diacerein is chosen.


Brittany Myers-O'Shea, PharmD

Latest:

White-Coat Hypertension: A Closer Look

Everything you need to know about WCH from diagnosis, treatment, and a review of the literature.


Lauren B. McKnight, PharmD, CPP

Latest:

Pain Management: Non-Opioid Medications

Given the disadvantages of opioids, including side effects and potential for addiction, non-opioid medications play an important role in pain management.


Eileen Stellefson Myers, MPH, RDN, LDN, CEDRD, FAND

Latest:

Nutrition Counseling for Patients with Prediabetes or Diabetes

More than 86 million Americans over the age of 20 have prediabetes, 29 million Americans are diagnosed with diabetes, and another 8.1 million Americans are living with undiagnosed diabetes.



Timothy D. Aungst, PharmD

Latest:

What is the Current Status of Bioingestible Sensors for Medication Adherence?

Sensors that can be attached to insulin pens, smart auto-injectors for patients with MS, sensors for inhalers, smart pill bottles, and bioingestible sensors are some of the evolving technologies.